Since 1992, Cambridge Healthtech Institute (CHI) has brought together the life science community to advance development of small molecule drugs, biologics and other therapeutic modalities. In the challenging environment of social distancing and quarantine, CHI, in the format of a series of interactive webinars, once again takes the leadership role of connecting the life science community by bringing you the latest research and technologies for new drug discovery and development. CHI’s Drug Discovery & Preclinical Webinar Series will feature cutting edge research starting from target identification and validation, to disease modeling, to non-clinical development of novel therapeutics. The webinars will be free for the drug discovery and development community around the world and will provide opportunities for virtual Q&A sessions, discussions and networking to keep us connected and informed in the current environment.